KURE ETF (KraneShares MSCI All China Health Care Index ETF) is managed by KraneShares with $67.3M in net assets. KURE expense ratio is 0.65%, holding 54 positions across sectors including Unknown. Inception date: 2018-01-31.

KURE performance shows a YTD return of -15.47%. The 1-year return is 2.07% and the 5-year return is -15.04%. KURE dividend yield stands at 4.43%, paid annually.

KURE top holdings include 1801:HK (9.2%), Beigene Ltd (8.6%), 6160:HK (8.5%), Jiangsu Hengrui Pharmaceuticals Co.,Ltd (8.0%), WUXI BIOLOGICS (CAYMAN) INC. (7.5%). View all KURE holdings, sector breakdown, or dividend history.

KURE can be compared against other funds using the overlap calculator or side-by-side comparison tool. KURE alternatives are available via the screener, along with tax-loss harvesting opportunities.